Cytotoxics in the pipeline: carrier-mediated anticancer agents in development

Novel cancer pharmacotherapeutics are progressing speedily and are being implemented to solve several limitations of conventional chemotherapy. In this review, we will focus on the types and characteristics of carriermediated anticancer agents, how they are being used as drug delivery, and possible future advances.